A dual cyclooxygenase-2 (COX-2) and soluble epoxide hydrolase (sEH) inhibitor PTUPB decreased proinflammatory cytokines and lipids in the TME and delayed ovarian tumor growth (112). The gene discussed is PTGS2; the disease is ovarian neoplasm.